Furthermore, either the knockout of the P2X7 receptor or the use of the P2X7 receptor antagonist A438079 notably reduced the formation of AAA in experimental mouse models, whereas the agonist ATP-γ-S remarkably accelerated AAA progression [28]. This evidence concerns the gene P2RX7 and triple-A syndrome.